Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infliximab and Basiliximab for Steroid-Refractory Acute GVHD
NCT01485055Phase 2Terminated
- Sponsor
- Nationwide Children's Hospital
- Start
- Dec 2011
- Primary completion
- Dec 2015
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of infliximab, basiliximab in Acute Graft-Versus-Host Disease (aGvHD), sponsored by Nationwide Children's Hospital. Started Dec 2011; status: terminated.
02
Drugs
infliximabbasiliximab
03
Conditions
Acute Graft-Versus-Host Disease (aGvHD)
Beyond the preview
Go deeper on NCT01485055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01485055.